17Dec
Related Posts
11Jun
MGM Wireless (ASX:MWR) launching Seniors wearable device in June
11 Jun 2020 - MGM Wireless Limited (ASX:MWR) CEO, Mark Fortunatow talks about growth in the company's SPACETALK brand of wearables for kids, new product categories, distribution, and growth in wearables from niche product to mainstream.
Read More
27Aug
LBT Innovations (ASX:LBT) automating the lab, August 2021
27 Aug 2021 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes provides an update on sales and distribution for the company's Automated Plate Assessment System (APAS), which is used to read culture plates in laboratories.
Read More
12May
Understanding credit investing with AL Capital
12 May 2025 - Phil Smith, a Director at AL Capital, discusses the company's strategy and focus on capital protection.
Read More
03Sep
Cardinal Resources (ASX:CDV) – West African gold explorer
03 Sep 2019 - Cardinal Resources Limited (ASX:CDV) Managing Director & CEO, Archie Koimtsidis talks about the company's Namdini Gold Project and Ghanaian regional exploration program.
Read More
20Mar
Elixinol Global (ASX:EXL) to acquire Cannacare Health
21 Mar 2021 - Elixinol Global (ASX:EXL) CEO, Oliver Horn talks about its proposed acquisition of CannaCare Health GmbH (CannaCare) one of Germany’s leading CBD (Cannabidiol) brands following the down scheduling of CBD in Europe late last year in what the Company sees as highly strategic opportunity and important pathway to profitability.
Read More
11Aug
AMCIL (ASX:AMH) FY25 full-year results
11 Aug 2025 - Mark Freeman, Managing Director, CEO and Portfolio Manager of AMCIL (ASX:AMH), discusses FY25 full-year results.
Read More
03Jun
Cyclopharm (ASX:CYC) US FDA progress for Technegas
03 Jun 2020 - Cyclopharm (ASX:CYC) Managing Director and CEO James McBrayer provides an update on US FDA progress with Technegas, approval in Russia and potential use of Technegas in the diagnosis and management of COVID-19.
Read More
28Sep
Cyclopharm (ASX:CYC) Technegas Phase 3 Trial meets primary endpoint
28 Sep 2020 - Cyclopharm Limited (ASX:CYC) Managing Director and CEO James McBrayer provides an update on the company's US Phase 3 trial for Technegas, and USFDA approval process timeline, with commercial sales expected in the US for 2021.
Read More
27Sep
Market update with Shaw and Partners, September 2024
27 Sep 2024 - Martin Crabb, Chief Investment Officer at Shaw and Partners, speaks on the mixed market outlook. He discusses growth, financial conditions, central bank policies and valuations. He advocates for a cautious approach focused on stock picking in the current climate, favouring small caps over large caps.
Read More
14Dec
RareX (ASX:REE) developing a top-three rare earths project in WA
14 Dec 2022 - RareX Limited (ASX:REE) Managing Director Jeremy Robinson discusses progress at the Cummins Range rare earths project and a potential resource upgrade.
Read More